Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (128)	5/31/1998 8:43:00 AM
From: Mick Mørmøny	Read Replies (1) \| Respond to of 1722

Hit Me Again, Doc VIAGRA Pfizer Inc.'s Viagra, the pill to treat impotence, had more refills even as the total number of prescriptions declined in the week ended May 15, according to IMS Health, an industry consulting group. The drop in total prescriptions came before the Food and Drug Administration said that six people taking the pill had died. The FDA said it could not confirm whether the deaths were linked to Viagra. After its introduction last month, Viagra has become one of the best-selling drugs in the United States, with more than one million prescriptions so far. Analysts expected demand to level off after men tried their first doses. Instead, the number of refills rose 46 percent, to 35,100, in the week ended May 15, while the total number of Viagra prescriptions fell to 297,666, or 1.9 percent, from 303,424 in the previous week, IMS Health said. NY Times, May 31, 1998